1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
C. diff Program: No Patient Left Behind is sponsored by The OpenBiome Foundation. The OpenBiome Foundation supports pioneering scientists and high-impact research that accelerates the future of microbiome therapies, specifically mentioning support for a randomized trial for MTP-301P, a novel powdered fecal microbiota transplant (FMT), to treat Clostridioides difficile infection (CDI) in hospitalized adults.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Research institutions and scientists focused on microbiome-based therapies and C. difficile treatment. Confirm the full requirements in the official notice before applying.
C. diff Program: No Patient Left Behind is funded by The OpenBiome Foundation. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program